FierceBiotech Feb 24, 2026 GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech
FierceBiotech Feb 24, 2026 Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics
FierceBiotech Feb 24, 2026 Allurion stock balloons as FDA signs off on its weight loss gastric system
FierceBiotech Feb 24, 2026 Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking
FierceBiotech Feb 24, 2026 Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months
FierceBiotech Feb 24, 2026 ‘The perfect partner’: Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific
FierceBiotech Feb 23, 2026 UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies
FierceBiotech Feb 23, 2026 MoonLake's phase 2 arthritis win kicks off pivotal year for IL-17 nanobody
FierceBiotech Feb 23, 2026 iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004